Back to top

Top Ranked Growth Stocks to Buy for July 26th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, July 26th:

Caleres, Inc. (CAL - Free Report) : This footwear retailer, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 1.4% over the last 60 days.

Caleres, Inc. Price and Consensus

Caleres, Inc. Price and Consensus | Caleres, Inc. Quote

Caleres has a PEG ratio 1.07, compared with 1.18 for the industry. The company possesses a Growth Score of A.

Hasbro, Inc. (HAS - Free Report) : This play and entertainment company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.2% over the last 60 days.

Hasbro, Inc. Price and Consensus

Hasbro, Inc. Price and Consensus | Hasbro, Inc. Quote

Hasbro has a PEG ratio 1.83, compared with 2.17 for the industry. The company possesses a Growth Score of A.

Chemours Company (CC - Free Report) : This chemical company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings advancing 4.5% over the last 60 days.

Chemours has a PEG ratio 0.85, compared with 1.74 for the industry. The company possesses a Growth Score of A.

Cigna Corporation (CI - Free Report) : This health services company, which carries a Zacks Rank #2 (Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.7% over the last 60 days.

Cigna has a PEG ratio 1.35, compared with 1.52 for the industry. The company possesses a Growth Score of A.

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.

5 Trades Could Profit "Big-League" from Trump Policies

If the stocks above spark your interest, wait until you look into companies primed to make substantial gains from Washington's changing course.

Today Zacks reveals 5 tickers that could benefit from new trends like streamlined drug approvals, tariffs, lower taxes, higher interest rates, and spending surges in defense and infrastructure. See these buy recommendations now >>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


Hasbro, Inc. (HAS) - free report >>

Cigna Corporation (CI) - free report >>

Chemours Company (The) (CC) - free report >>

Caleres, Inc. (CAL) - free report >>


More from Zacks Zacks #1 Rank Additions

You May Like